Advertisement

< Back to Article

The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study

Table 3

Reclassification in 653 participants classified as CKD G3aA1 by eGFRcreat at baseline using eGFRcys and eGFRcreat-cys.

Table 3

doi: https://doi.org/10.1371/journal.pmed.1002400.t003